FS Development Corp II Cl A (FSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FSII | TKNO | EDIT | ||
| Company | FS Development Corp II Cl A | Alpha Teknova Inc | Editas Medicine | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.05 | 3.81 | 2.06 | ||
| High | 10.16 | 3.94 | 2.08 | ||
| Low | 9.69 | 3.78 | 1.97 | ||
| Latest | 9.80 | 3.90 | 2.05 | ||
| Change | -0.20 | +0.10 | unch | ||
| % Change | -2.00% | +2.63% | unch | ||
| Volume | 289,100 | 141,957 | 2,042,469 | ||
| 20-Day Average Volume | 227,795 | 168,548 | 1,758,328 | ||
| Previous Close | 10.00 | 3.80 | 2.05 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.86 | 4.43 | 2.33 | ||
| 20-Day Raw Stochastic | 2.99% | 22.68% | 10.96% | ||
| 20-Day Relative Strength | 38.90 | 37.16 | 35.45 | ||
| Weighted Alpha | -13.88 | -58.97 | -2.80 | ||
| Today's Opinion | 8% Buy | 100% Sell | 72% Sell | ||
| Previous Opinion | 8% Buy | 100% Sell | 72% Sell | ||
| Last Month's Opinion | 72% Buy | 88% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.89% since 12/16/21 | -5.11% since 12/24/25 | -7.24% since 12/24/25 | ||
| Low | 9.64 on 12/21/21 | 3.60 on 12/29/25 | 1.97 on 01/02/26 | ||
| High | 10.86 on 12/21/21 | 4.11 on 12/26/25 | 2.20 on 12/26/25 | ||
| 1-Month | |||||
| %Chg | -30.10% since 11/23/21 | -11.76% since 12/02/25 | -2.84% since 12/02/25 | ||
| Low | 9.64 on 12/21/21 | 3.60 on 12/29/25 | 1.97 on 01/02/26 | ||
| High | 15.00 on 12/01/21 | 4.94 on 12/12/25 | 2.70 on 12/11/25 | ||
| 3-Month | |||||
| %Chg | -1.90% since 09/23/21 | -36.59% since 10/02/25 | -47.30% since 10/02/25 | ||
| Low | 9.64 on 12/21/21 | 3.60 on 12/29/25 | 1.97 on 01/02/26 | ||
| High | 15.05 on 11/19/21 | 6.68 on 10/03/25 | 4.54 on 10/08/25 | ||
| 6-Month | |||||
| %Chg | -0.81% since 06/23/21 | -23.38% since 07/02/25 | -19.92% since 07/02/25 | ||
| Low | 9.64 on 12/21/21 | 3.60 on 12/29/25 | 1.97 on 01/02/26 | ||
| High | 15.05 on 11/19/21 | 6.68 on 10/03/25 | 4.54 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 203,125 | 203,410 | 200,119 | ||
| Shares Outstanding, K | 20,727 | 53,529 | 97,619 | ||
| Annual Sales | 0 | 37,750,000 | 32,310,000 | ||
| Annual Net Income | 0 | -26,750,000 | -237,090,000 | ||
| Last Quarter Sales | 0 | 10,450,000 | 7,540,000 | ||
| Last Quarter Net Income | -1,220,000 | -4,290,000 | -25,120,000 | ||
| 60-Month Beta | N/A | 0.40 | 2.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/12/21 | -0.08 on 11/06/25 | -0.28 on 11/10/25 | ||
| Latest Earnings Date | 01/01/70 | 03/03/26 | 03/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||